DPP4 and endothelial dysfunction: In short, when endothelial dysfunction progresses to atherosclerosis and the risk of developing thromboembolism increases, DPP-4 inhibitors show beneficial effects there (Table 1; Figure 1) by suppressing macrophage infiltration, the formation of foam cells, and the proliferation of smooth muscle cells.